Form 4 for NOC Northrop Grumman
Accepted 2022-02-17 00:00:00 ET · period of report 2022-02-15 · accession 0001628280-22-003037 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-02-17 | 2022-02-15 | NOC | CHESTON SHEILA C. | GC, Corp. VP | M - OptEx | $0.00 | +8,191 | 38.8K | +27% | $0 |
| D | 2022-02-17 | 2022-02-15 | NOC | CHESTON SHEILA C. | GC, Corp. VP | F - Tax | $384.77 | -3,957 | 34.8K | -10% | -$1.52M |
| D | 2022-02-17 | 2022-02-15 | NOC | CHESTON SHEILA C. | GC, Corp. VP | M - OptEx | $0.00 | -8,191 | 16.1K | -34% | $0 |
| DM | 2022-02-17 | 2022-02-15 | NOC | CHESTON SHEILA C. | GC, Corp. VP | A - Grant | $0.00 | +8,270 | 7,182 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-02-15 | M | A | 8,191 | $0.00 | 38,754.86 | D | — | — | |
| 2 | Common | Common Stock | 2022-02-15 | F | D | 3,957 | $384.77 | 34,797.86 | D | — | — | |
| 3 | Derivative | Restricted Performance Stock Rights | 2022-02-15 | M | D | 8,191 | $0.00 | 16,129 | D | — · — to — | 8,191 Common Stock | (F2) Each Restricted Performance Stock Right ("RPSR") represents a contingent right to receive an equivalent number of shares of Issuer common stock, or, at the Issuer's election, cash or a combination of cash and Issuer common stock. The RPSRs vest if the applicable performance metric is satisfied for the relevant measurement period. Grants awarded pursuant to Rule 16b-3(d). |
| 4 | Derivative | Restricted Performance Stock Rights | 2022-02-15 | A | A | 6,140 | $0.00 | 24,320 | D | — · — to — | 6,140 Common Stock | (F3) The RPSRs acquired include (i) 1,477 vested RPSRs with respect to the measurement period ended 12/31/21 acquired due to settlement of the RPSRs granted under the 2011 Long-Term Incentive Stock Plan ("LTISP") on 2/13/19 that resulted in settlement at 122% of the target award; and (ii) 4,663 unvested RPSRs granted under the LTISP on 2/15/22 with a measurement period ending on 12/31/24. A total of 8,191 shares were issued in settlement of the 2019 RPSRs with a measurement period that ended 12/31/21, and the target award amount of 6,714 RPSRs was previously reported in connection with the grant of the 2019 RPSRs. (F2) Each Restricted Performance Stock Right ("RPSR") represents a contingent right to receive an equivalent number of shares of Issuer common stock, or, at the Issuer's election, cash or a combination of cash and Issuer common stock. The RPSRs vest if the applicable performance metric is satisfied for the relevant measurement period. Grants awarded pursuant to Rule 16b-3(d). |
| 5 | Derivative | Restricted Stock Rights | 2022-02-15 | A | A | 2,130 | $0.00 | 7,182 | D | — · — to — | 2,130 Common Stock | (F1) Each Restricted Stock Right ("RSR") represents a contingent right to receive an equivalent number of shares in Issuer common stock, or, at the election of the Issuer's Compensation Committee, cash or a combination of cash and Issuer common stock. The RSRs were granted under the Long-Term Incentive Stock Plan ("LTISP") on 2/15/22 and will vest on 2/18/25. |